Sernova Corp. (TSE:SVA – Get Free Report) hit a new 52-week low on Monday . The company traded as low as C$0.16 and last traded at C$0.17, with a volume of 499410 shares traded. The stock had previously closed at C$0.18.
Sernova Price Performance
The stock has a market cap of C$55.52 million, a P/E ratio of -1.59 and a beta of 1.35. The firm has a 50 day simple moving average of C$0.20 and a 200-day simple moving average of C$0.23. The company has a quick ratio of 18.11, a current ratio of 0.32 and a debt-to-equity ratio of -4.40.
Sernova Company Profile
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Recommended Stories
- Five stocks we like better than Sernova
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Energy Transfer: Powering Data With Dividends and Diversification
- What Does a Stock Split Mean?
- Qualcomm Stock Is Coiling for a Breakout
- Want to Profit on the Downtrend? Downtrends, Explained.
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
